A Successful Synthetic

The Ebola virus currently in the Democratic Republic of the Congo is notoriously elusive—especially for scientists wanting to study it.

Samples from the DRC’s last 4 outbreaks have not been shared internationally. 

In response, the CDC responded created a synthetic version. Published yesterday in the Lancet Infectious Diseases, the study used the synthetic virus to confirm tests and treatments based on earlier versions of the virus were indeed effective against the latest strain.

Other scientists note it would have been easier—and cheaper—to test samples direct from the DRC, rather than cloning the virus with reverse genetics. 


Comments +


Post a Comment

Restricted HTML

  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Back to top